FLORENCE, S.C., Dec. 18, 2015 (GLOBE NEWSWIRE) -- DeGen Medical has received clearance from the FDA for our cervical interbody fusion device - Latitude-C™ Cervical Interbody Spacer System. Latitude-C™ Cervical Interbody Spacer offers the surgeon a wide variety of materials based on patient needs – PEEK-OPTIMA®, Porous Titanium with PEEK, PEEK-OPTIMA® HA Enhanced, Titanium and Carbon fiber-reinforced (CFR) PEEK-OPTIMA®.
|
|||||
The Latitude-C™ Cervical Interbody Spacer is unique, patent pending design considers the uncinate process of the cervical vertebra. The lateral angles of the Latitude-C™ cervical spacer device are unique to match individual patient anatomy and different angles allow for perfect fit at every fusion level.
"The Latitude-C™ graft is a tectonic shift away from traditional rectangular shape cervical grafts. The trapezoidal shape is tremendous improvement in respecting the correct anatomy of patients," says Dr.Chokshi at Pee Dee Spine Center, Florence, SC.
The Latitude-C™ Cervical Interbody fusion devices come in variety of shapes and sizes:
- 5 different footprints from 12x12mm to 20x15mm and each size has 10 heights - 5 to 14mm
- There are 3 different shape options to choose from – Anatomic, Lordotic and Parallel
- The system is delivered in several color coded options for procedural flexibility
The Latitude-C™ interbody fusion devices will be available in Q1 of 2016.
About DeGen Medical, Inc.
DeGen Medical, Inc. is a medical-device development company dedicated to providing surgeons with innovative products engineered to improve quality of life for patients with complex spinal disorders. World-class implants, coupled with intuitively-designed instrumentation, provide a complete package to promote superior surgical outcomes. Our passion to advance spine-care solutions is driven by clinical insights, sound research, and science-based design. DeGen Medical maintains the highest quality standards to provide reliable products and safeguard patient health.
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=38239
CONTACT: Jessica Clark
DeGen Medical, Inc.
Phone: 877-240-7838
www.DeGenmedical.com


Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut
US Raises Concerns Over Possible ASML EUV Machine Transfer to China
Trump Says Anthropic No Longer Seen as National Security Threat
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 



